| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| beta Catenin | 13 | 2024 | 267 | 3.910 |
Why?
|
| Thymus Gland | 15 | 2024 | 197 | 2.690 |
Why?
|
| Thymocytes | 7 | 2024 | 31 | 2.620 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 8 | 2022 | 80 | 2.080 |
Why?
|
| T-Lymphocytes | 20 | 2020 | 1229 | 1.980 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2022 | 455 | 1.340 |
Why?
|
| T-Lymphocytes, Regulatory | 10 | 2021 | 314 | 1.300 |
Why?
|
| Lymphocyte Activation | 12 | 2021 | 756 | 1.290 |
Why?
|
| Genomic Instability | 3 | 2022 | 84 | 1.230 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 4 | 2022 | 54 | 1.220 |
Why?
|
| Proto-Oncogene Proteins c-myc | 6 | 2022 | 130 | 1.140 |
Why?
|
| T Cell Transcription Factor 1 | 5 | 2021 | 23 | 1.130 |
Why?
|
| Mice | 57 | 2024 | 11949 | 1.130 |
Why?
|
| Lymphopoiesis | 3 | 2019 | 48 | 1.070 |
Why?
|
| Wnt Signaling Pathway | 3 | 2022 | 103 | 0.980 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 11 | 2009 | 100 | 0.960 |
Why?
|
| Cell Differentiation | 16 | 2024 | 1553 | 0.930 |
Why?
|
| Cell Proliferation | 14 | 2021 | 1695 | 0.890 |
Why?
|
| Translocation, Genetic | 2 | 2022 | 264 | 0.860 |
Why?
|
| Animals | 69 | 2024 | 27715 | 0.850 |
Why?
|
| Gene Expression Regulation | 10 | 2021 | 1991 | 0.840 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2020 | 453 | 0.840 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2024 | 177 | 0.770 |
Why?
|
| Wnt Proteins | 1 | 2022 | 131 | 0.760 |
Why?
|
| Mice, Transgenic | 18 | 2021 | 1583 | 0.750 |
Why?
|
| Cellular Reprogramming | 1 | 2021 | 41 | 0.720 |
Why?
|
| Mice, Inbred C57BL | 16 | 2024 | 3278 | 0.710 |
Why?
|
| Ikaros Transcription Factor | 4 | 2016 | 25 | 0.700 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2020 | 128 | 0.690 |
Why?
|
| Colonic Neoplasms | 4 | 2021 | 572 | 0.660 |
Why?
|
| Natural Killer T-Cells | 3 | 2009 | 46 | 0.660 |
Why?
|
| Epigenesis, Genetic | 4 | 2024 | 526 | 0.620 |
Why?
|
| Cell Lineage | 7 | 2019 | 296 | 0.590 |
Why?
|
| T-Lymphocyte Subsets | 5 | 2015 | 277 | 0.580 |
Why?
|
| Lymphoma | 4 | 2015 | 268 | 0.570 |
Why?
|
| CD4 Antigens | 2 | 2018 | 83 | 0.560 |
Why?
|
| Signal Transduction | 16 | 2020 | 3431 | 0.560 |
Why?
|
| Receptors, Antigen, T-Cell | 6 | 2010 | 407 | 0.520 |
Why?
|
| Disease Models, Animal | 6 | 2021 | 2409 | 0.510 |
Why?
|
| Mast Cells | 5 | 2019 | 94 | 0.500 |
Why?
|
| Intermediate Filament Proteins | 6 | 1997 | 35 | 0.470 |
Why?
|
| Cytoskeletal Proteins | 4 | 2005 | 229 | 0.460 |
Why?
|
| Crohn Disease | 1 | 2021 | 765 | 0.460 |
Why?
|
| Genetics | 1 | 2014 | 24 | 0.460 |
Why?
|
| Mice, Inbred BALB C | 8 | 2024 | 1095 | 0.450 |
Why?
|
| Colitis, Ulcerative | 1 | 2021 | 763 | 0.450 |
Why?
|
| B-Lymphocytes | 5 | 2019 | 741 | 0.430 |
Why?
|
| Receptors, Notch | 7 | 2015 | 127 | 0.430 |
Why?
|
| Eye Proteins | 6 | 1997 | 128 | 0.430 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 155 | 0.430 |
Why?
|
| Mice, Knockout | 16 | 2021 | 2042 | 0.430 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2014 | 135 | 0.410 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2024 | 602 | 0.410 |
Why?
|
| Trans-Activators | 4 | 2005 | 443 | 0.410 |
Why?
|
| Transgenes | 2 | 2012 | 185 | 0.410 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 3 | 2021 | 19 | 0.400 |
Why?
|
| Colon | 3 | 2019 | 522 | 0.400 |
Why?
|
| Leukemia | 2 | 2013 | 320 | 0.390 |
Why?
|
| Lymphocytes | 3 | 2018 | 470 | 0.380 |
Why?
|
| Mutagenesis, Insertional | 1 | 2011 | 114 | 0.370 |
Why?
|
| Colitis | 1 | 2014 | 249 | 0.360 |
Why?
|
| Genes, APC | 2 | 2014 | 27 | 0.360 |
Why?
|
| Cell Survival | 7 | 2019 | 987 | 0.340 |
Why?
|
| Base Sequence | 18 | 2013 | 2329 | 0.330 |
Why?
|
| Adenomatous Polyposis Coli Protein | 3 | 2012 | 41 | 0.330 |
Why?
|
| Cells, Cultured | 10 | 2021 | 2895 | 0.320 |
Why?
|
| Enhancer Elements, Genetic | 4 | 2016 | 284 | 0.320 |
Why?
|
| Cytokines | 5 | 2021 | 814 | 0.320 |
Why?
|
| Th17 Cells | 3 | 2021 | 86 | 0.310 |
Why?
|
| Transcription Factors | 11 | 2019 | 1670 | 0.310 |
Why?
|
| DNA Breaks, Double-Stranded | 2 | 2022 | 67 | 0.300 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2019 | 667 | 0.300 |
Why?
|
| Membrane Glycoproteins | 4 | 2004 | 434 | 0.300 |
Why?
|
| Precursor Cells, B-Lymphoid | 2 | 2019 | 27 | 0.290 |
Why?
|
| Selection, Genetic | 2 | 2011 | 519 | 0.290 |
Why?
|
| Chromatin | 2 | 2022 | 408 | 0.290 |
Why?
|
| Bone Marrow Cells | 2 | 2011 | 263 | 0.290 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 2 | 2024 | 97 | 0.280 |
Why?
|
| Intermediate Filaments | 5 | 2000 | 16 | 0.270 |
Why?
|
| Intestinal Neoplasms | 2 | 2018 | 69 | 0.260 |
Why?
|
| Receptors, Cell Surface | 2 | 2009 | 289 | 0.250 |
Why?
|
| Transcription, Genetic | 7 | 2021 | 1161 | 0.250 |
Why?
|
| Adenomatous Polyposis Coli | 4 | 2021 | 39 | 0.250 |
Why?
|
| Molecular Sequence Data | 15 | 2013 | 3030 | 0.240 |
Why?
|
| Interleukin-10 | 3 | 2015 | 155 | 0.240 |
Why?
|
| Flow Cytometry | 7 | 2013 | 695 | 0.240 |
Why?
|
| Forkhead Transcription Factors | 3 | 2021 | 173 | 0.240 |
Why?
|
| Intestine, Small | 2 | 2018 | 299 | 0.230 |
Why?
|
| Protein Stability | 1 | 2024 | 101 | 0.230 |
Why?
|
| Lectins, C-Type | 1 | 2024 | 86 | 0.230 |
Why?
|
| Genes | 3 | 1997 | 306 | 0.220 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2021 | 1286 | 0.220 |
Why?
|
| Leukocyte Common Antigens | 1 | 2003 | 48 | 0.220 |
Why?
|
| Skin Transplantation | 1 | 2024 | 187 | 0.210 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2002 | 19 | 0.200 |
Why?
|
| Recombination, Genetic | 4 | 2019 | 446 | 0.200 |
Why?
|
| Cell Nucleus | 2 | 2022 | 605 | 0.200 |
Why?
|
| DNA-Binding Proteins | 6 | 2014 | 1247 | 0.200 |
Why?
|
| Promoter Regions, Genetic | 7 | 2013 | 961 | 0.200 |
Why?
|
| Lymph Nodes | 2 | 2012 | 553 | 0.200 |
Why?
|
| Homeodomain Proteins | 4 | 2010 | 558 | 0.190 |
Why?
|
| Hematopoiesis | 1 | 2002 | 169 | 0.180 |
Why?
|
| RNA, Long Noncoding | 1 | 2022 | 120 | 0.180 |
Why?
|
| DNA, Complementary | 4 | 2009 | 391 | 0.180 |
Why?
|
| Phenotype | 5 | 2021 | 2473 | 0.180 |
Why?
|
| Bone Marrow | 2 | 2019 | 446 | 0.180 |
Why?
|
| Cyclin-Dependent Kinase 6 | 2 | 2011 | 14 | 0.170 |
Why?
|
| Receptors, Prostaglandin | 1 | 2020 | 7 | 0.170 |
Why?
|
| Nedd4 Ubiquitin Protein Ligases | 1 | 2020 | 13 | 0.170 |
Why?
|
| Cell Adhesion Molecules | 1 | 2020 | 166 | 0.170 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2021 | 320 | 0.170 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2019 | 96 | 0.160 |
Why?
|
| Receptors, CXCR4 | 1 | 2019 | 46 | 0.160 |
Why?
|
| Lac Operon | 1 | 1998 | 47 | 0.160 |
Why?
|
| CD8 Antigens | 1 | 2018 | 82 | 0.160 |
Why?
|
| DNA Helicases | 1 | 2019 | 84 | 0.160 |
Why?
|
| Membrane Proteins | 4 | 2021 | 1232 | 0.160 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2019 | 117 | 0.160 |
Why?
|
| T-Box Domain Proteins | 1 | 2020 | 126 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2005 | 888 | 0.150 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2021 | 290 | 0.150 |
Why?
|
| Homeostasis | 1 | 2020 | 425 | 0.150 |
Why?
|
| Gene Expression Regulation, Leukemic | 2 | 2016 | 93 | 0.150 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2002 | 1096 | 0.150 |
Why?
|
| Chymases | 1 | 2018 | 11 | 0.150 |
Why?
|
| Binding Sites | 5 | 2015 | 1127 | 0.150 |
Why?
|
| Immunologic Surveillance | 2 | 2015 | 14 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-kit | 2 | 2011 | 79 | 0.150 |
Why?
|
| Pyrimethamine | 1 | 2017 | 21 | 0.150 |
Why?
|
| Mucous Membrane | 1 | 2018 | 83 | 0.150 |
Why?
|
| Exons | 5 | 2005 | 453 | 0.140 |
Why?
|
| STAT3 Transcription Factor | 1 | 2017 | 88 | 0.140 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 2009 | 105 | 0.140 |
Why?
|
| Cell Movement | 3 | 2015 | 793 | 0.140 |
Why?
|
| Stem Cells | 3 | 2011 | 380 | 0.140 |
Why?
|
| Anti-Infective Agents | 1 | 2017 | 91 | 0.140 |
Why?
|
| Humans | 27 | 2021 | 90640 | 0.140 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2014 | 78 | 0.130 |
Why?
|
| Adjuvants, Immunologic | 1 | 2017 | 169 | 0.130 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1873 | 0.130 |
Why?
|
| Inflammation | 4 | 2021 | 990 | 0.130 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2013 | 309 | 0.130 |
Why?
|
| Cell Line, Tumor | 4 | 2017 | 2609 | 0.130 |
Why?
|
| Receptors, CCR | 1 | 2015 | 4 | 0.120 |
Why?
|
| Receptor, Notch1 | 2 | 2008 | 94 | 0.120 |
Why?
|
| Lymphoid Progenitor Cells | 1 | 2015 | 16 | 0.120 |
Why?
|
| Green Fluorescent Proteins | 2 | 2013 | 309 | 0.120 |
Why?
|
| Aging | 1 | 2020 | 730 | 0.120 |
Why?
|
| Histones | 2 | 2013 | 344 | 0.120 |
Why?
|
| Genes, RAG-1 | 1 | 2013 | 13 | 0.110 |
Why?
|
| Spleen | 2 | 2012 | 433 | 0.110 |
Why?
|
| Homologous Recombination | 1 | 2014 | 53 | 0.110 |
Why?
|
| Apoptosis | 3 | 2013 | 1725 | 0.110 |
Why?
|
| United Kingdom | 1 | 2014 | 167 | 0.110 |
Why?
|
| Amino Acid Sequence | 8 | 2000 | 2077 | 0.110 |
Why?
|
| Immunomodulation | 1 | 2013 | 58 | 0.110 |
Why?
|
| Protein Structure, Secondary | 2 | 1993 | 335 | 0.110 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 2 | 1990 | 35 | 0.110 |
Why?
|
| Receptors, Interleukin-2 | 2 | 2003 | 67 | 0.100 |
Why?
|
| History, 20th Century | 1 | 2014 | 315 | 0.100 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2013 | 156 | 0.100 |
Why?
|
| Repressor Proteins | 2 | 2013 | 428 | 0.100 |
Why?
|
| Lactobacillus acidophilus | 1 | 2012 | 7 | 0.100 |
Why?
|
| Integrases | 1 | 2012 | 63 | 0.100 |
Why?
|
| NF-kappa B | 2 | 2009 | 469 | 0.100 |
Why?
|
| Gene Targeting | 1 | 2012 | 74 | 0.100 |
Why?
|
| Teichoic Acids | 1 | 2012 | 18 | 0.100 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 295 | 0.100 |
Why?
|
| Epithelial Cells | 1 | 2016 | 693 | 0.100 |
Why?
|
| RNA, Messenger | 6 | 2015 | 2034 | 0.100 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 403 | 0.100 |
Why?
|
| Cell Cycle | 2 | 2006 | 511 | 0.100 |
Why?
|
| Antineoplastic Agents | 2 | 2017 | 2337 | 0.100 |
Why?
|
| Neoplasms | 3 | 2013 | 3030 | 0.100 |
Why?
|
| Genetic Engineering | 1 | 2012 | 116 | 0.100 |
Why?
|
| DNA Methylation | 2 | 2013 | 666 | 0.100 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2011 | 5 | 0.100 |
Why?
|
| Immunologic Memory | 2 | 2024 | 165 | 0.100 |
Why?
|
| Tamoxifen | 1 | 2012 | 167 | 0.100 |
Why?
|
| DNA Repair | 1 | 2013 | 363 | 0.090 |
Why?
|
| Antigens, Neoplasm | 1 | 2013 | 335 | 0.090 |
Why?
|
| Evolution, Molecular | 1 | 1997 | 857 | 0.090 |
Why?
|
| Phospholipase C gamma | 1 | 2010 | 15 | 0.090 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2013 | 419 | 0.090 |
Why?
|
| Lipopolysaccharides | 1 | 2012 | 295 | 0.090 |
Why?
|
| Aneuploidy | 1 | 2010 | 57 | 0.090 |
Why?
|
| Adenoviruses, Human | 1 | 1990 | 41 | 0.090 |
Why?
|
| Genes, myc | 2 | 2008 | 40 | 0.090 |
Why?
|
| Signaling Lymphocytic Activation Molecule Family Member 1 | 1 | 2009 | 4 | 0.080 |
Why?
|
| Signaling Lymphocytic Activation Molecule Associated Protein | 1 | 2009 | 5 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2009 | 23 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 220 | 0.080 |
Why?
|
| Antigens, CD1d | 1 | 2009 | 32 | 0.080 |
Why?
|
| Nuclear Proteins | 5 | 2001 | 728 | 0.080 |
Why?
|
| Phosphoproteins | 1 | 2010 | 262 | 0.080 |
Why?
|
| DNA Replication | 1 | 1990 | 172 | 0.080 |
Why?
|
| DNA, Viral | 1 | 1990 | 265 | 0.080 |
Why?
|
| Down-Regulation | 1 | 2010 | 521 | 0.080 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2009 | 102 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 315 | 0.080 |
Why?
|
| Mice, Mutant Strains | 3 | 2007 | 231 | 0.080 |
Why?
|
| Thymus Neoplasms | 1 | 2009 | 43 | 0.080 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2009 | 198 | 0.080 |
Why?
|
| Chromosome Aberrations | 2 | 2010 | 384 | 0.080 |
Why?
|
| Hematopoietic System | 1 | 2007 | 13 | 0.070 |
Why?
|
| Cattle | 5 | 1996 | 379 | 0.070 |
Why?
|
| Antigens, CD | 1 | 2009 | 467 | 0.070 |
Why?
|
| DNA | 4 | 1993 | 1314 | 0.070 |
Why?
|
| Polyps | 1 | 2007 | 29 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2009 | 388 | 0.070 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2007 | 16 | 0.070 |
Why?
|
| Models, Genetic | 3 | 2013 | 952 | 0.070 |
Why?
|
| Cloning, Molecular | 4 | 1997 | 646 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2010 | 665 | 0.070 |
Why?
|
| Azacitidine | 1 | 1987 | 148 | 0.070 |
Why?
|
| Lymphoma, T-Cell | 1 | 2007 | 58 | 0.070 |
Why?
|
| Alleles | 2 | 2011 | 1138 | 0.070 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 1129 | 0.060 |
Why?
|
| VDJ Recombinases | 1 | 2005 | 3 | 0.060 |
Why?
|
| Female | 10 | 2024 | 46894 | 0.060 |
Why?
|
| Metaphase | 1 | 2005 | 24 | 0.060 |
Why?
|
| Anaphase | 1 | 2005 | 20 | 0.060 |
Why?
|
| Chromosome Banding | 1 | 2005 | 73 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2007 | 342 | 0.060 |
Why?
|
| Transcription Initiation Site | 1 | 2005 | 46 | 0.060 |
Why?
|
| Retroviridae | 1 | 2005 | 79 | 0.060 |
Why?
|
| Mitosis | 1 | 2005 | 152 | 0.060 |
Why?
|
| Cytokinesis | 1 | 2005 | 57 | 0.060 |
Why?
|
| Methionine | 1 | 2005 | 67 | 0.060 |
Why?
|
| Immunity, Cellular | 2 | 2011 | 179 | 0.060 |
Why?
|
| Male | 8 | 2024 | 42967 | 0.060 |
Why?
|
| Gene Rearrangement | 1 | 2005 | 177 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 2 | 2005 | 923 | 0.060 |
Why?
|
| Cricetinae | 3 | 1996 | 560 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2002 | 795 | 0.050 |
Why?
|
| Protein Binding | 4 | 2015 | 1500 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 3020 | 0.050 |
Why?
|
| Antigens, CD19 | 1 | 2003 | 61 | 0.050 |
Why?
|
| Lens, Crystalline | 2 | 1994 | 69 | 0.050 |
Why?
|
| Clonal Deletion | 1 | 2003 | 23 | 0.050 |
Why?
|
| DNA Primers | 3 | 2004 | 546 | 0.050 |
Why?
|
| Vimentin | 2 | 2000 | 46 | 0.050 |
Why?
|
| Transplantation Tolerance | 1 | 2024 | 138 | 0.050 |
Why?
|
| Solute Carrier Family 12, Member 2 | 1 | 2002 | 16 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 2370 | 0.050 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 1 | 2002 | 22 | 0.050 |
Why?
|
| Subcellular Fractions | 1 | 2002 | 94 | 0.050 |
Why?
|
| Adoptive Transfer | 2 | 2015 | 170 | 0.050 |
Why?
|
| Metaplasia | 1 | 2002 | 37 | 0.050 |
Why?
|
| Rats | 3 | 2006 | 4061 | 0.050 |
Why?
|
| Immunophenotyping | 2 | 2015 | 218 | 0.050 |
Why?
|
| Cell Line | 5 | 2015 | 2505 | 0.050 |
Why?
|
| Sp1 Transcription Factor | 2 | 2020 | 22 | 0.050 |
Why?
|
| Receptors, Androgen | 1 | 2002 | 119 | 0.050 |
Why?
|
| Cadherins | 1 | 2002 | 164 | 0.050 |
Why?
|
| Cell Division | 2 | 2002 | 692 | 0.050 |
Why?
|
| Gene Products, rex | 2 | 1998 | 2 | 0.050 |
Why?
|
| Sequence Deletion | 1 | 2001 | 205 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2000 | 48 | 0.040 |
Why?
|
| Genotype | 1 | 2005 | 1855 | 0.040 |
Why?
|
| Calcium Signaling | 1 | 2001 | 139 | 0.040 |
Why?
|
| RNA | 2 | 2003 | 588 | 0.040 |
Why?
|
| Gene Expression Profiling | 3 | 2011 | 1462 | 0.040 |
Why?
|
| Prostaglandin D2 | 1 | 2020 | 28 | 0.040 |
Why?
|
| Connective Tissue | 1 | 2019 | 23 | 0.040 |
Why?
|
| Gene Regulatory Networks | 2 | 2013 | 309 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2007 | 974 | 0.040 |
Why?
|
| Superoxides | 1 | 2020 | 74 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2020 | 75 | 0.040 |
Why?
|
| Chemokine CXCL12 | 1 | 2019 | 38 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2020 | 108 | 0.040 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2019 | 68 | 0.040 |
Why?
|
| Interferon Regulatory Factors | 1 | 2019 | 70 | 0.040 |
Why?
|
| CHO Cells | 2 | 1996 | 189 | 0.040 |
Why?
|
| Th1 Cells | 1 | 2020 | 166 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 1998 | 71 | 0.040 |
Why?
|
| S Phase | 1 | 1998 | 63 | 0.040 |
Why?
|
| Mice, Inbred DBA | 1 | 1998 | 150 | 0.040 |
Why?
|
| Leukemia Virus, Murine | 1 | 1998 | 18 | 0.040 |
Why?
|
| Structure-Activity Relationship | 2 | 1997 | 429 | 0.040 |
Why?
|
| Graft Rejection | 1 | 2024 | 1084 | 0.040 |
Why?
|
| Mice, SCID | 1 | 1998 | 260 | 0.040 |
Why?
|
| Gene Expression | 2 | 2007 | 1313 | 0.040 |
Why?
|
| Antihypertensive Agents | 1 | 2020 | 258 | 0.040 |
Why?
|
| Polymers | 2 | 1996 | 199 | 0.040 |
Why?
|
| HeLa Cells | 3 | 1998 | 520 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 2 | 1997 | 565 | 0.040 |
Why?
|
| Cancer Vaccines | 1 | 1998 | 159 | 0.040 |
Why?
|
| Nuclear Envelope | 1 | 1997 | 38 | 0.040 |
Why?
|
| Tumor Escape | 1 | 2017 | 51 | 0.040 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2017 | 217 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 1997 | 211 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2017 | 397 | 0.030 |
Why?
|
| Polycomb-Group Proteins | 1 | 2016 | 9 | 0.030 |
Why?
|
| Gene Dosage | 1 | 1997 | 210 | 0.030 |
Why?
|
| Pregnancy | 1 | 2024 | 3070 | 0.030 |
Why?
|
| Vaccination | 1 | 1998 | 280 | 0.030 |
Why?
|
| Chromosome Mapping | 2 | 1997 | 1074 | 0.030 |
Why?
|
| Introns | 1 | 1997 | 302 | 0.030 |
Why?
|
| Mutation | 1 | 1987 | 4183 | 0.030 |
Why?
|
| Gene Deletion | 2 | 2010 | 345 | 0.030 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2015 | 29 | 0.030 |
Why?
|
| Antigens, Surface | 1 | 2015 | 102 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2002 | 1182 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 1998 | 1066 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 1996 | 1049 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 1997 | 872 | 0.030 |
Why?
|
| Hypertension | 1 | 2020 | 746 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2010 | 1132 | 0.030 |
Why?
|
| Macromolecular Substances | 2 | 1993 | 177 | 0.030 |
Why?
|
| Precipitin Tests | 1 | 1993 | 111 | 0.030 |
Why?
|
| Y-Box-Binding Protein 1 | 2 | 1990 | 2 | 0.030 |
Why?
|
| NFI Transcription Factors | 2 | 1990 | 7 | 0.030 |
Why?
|
| Myeloid Cells | 1 | 2013 | 103 | 0.030 |
Why?
|
| Intestinal Polyps | 1 | 2012 | 27 | 0.030 |
Why?
|
| Mice, Inbred C3H | 1 | 2013 | 371 | 0.030 |
Why?
|
| CpG Islands | 1 | 2013 | 158 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2013 | 274 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2013 | 178 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 1996 | 1015 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 2019 | 0.020 |
Why?
|
| Organ Specificity | 1 | 1993 | 279 | 0.020 |
Why?
|
| Nucleotide Motifs | 1 | 2011 | 49 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2011 | 29 | 0.020 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2011 | 37 | 0.020 |
Why?
|
| Cytoplasm | 2 | 2002 | 286 | 0.020 |
Why?
|
| Coxsackie and Adenovirus Receptor-Like Membrane Protein | 1 | 2010 | 12 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 2013 | 344 | 0.020 |
Why?
|
| Spectral Karyotyping | 1 | 2010 | 2 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2010 | 39 | 0.020 |
Why?
|
| Trisomy | 1 | 2010 | 54 | 0.020 |
Why?
|
| Receptors, Virus | 1 | 2010 | 75 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1987 | 243 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 1998 | 1549 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 1990 | 108 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1990 | 39 | 0.020 |
Why?
|
| Aged | 2 | 2020 | 19424 | 0.020 |
Why?
|
| Vaccinia virus | 1 | 1990 | 19 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2013 | 451 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 1990 | 146 | 0.020 |
Why?
|
| Organ Size | 1 | 2010 | 375 | 0.020 |
Why?
|
| Promyelocytic Leukemia Zinc Finger Protein | 1 | 2009 | 15 | 0.020 |
Why?
|
| Antigen Presentation | 1 | 2011 | 215 | 0.020 |
Why?
|
| Plasmids | 1 | 1990 | 292 | 0.020 |
Why?
|
| Dermatitis | 1 | 2009 | 34 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2009 | 21 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 570 | 0.020 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 2008 | 17 | 0.020 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 2008 | 9 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2010 | 531 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2009 | 85 | 0.020 |
Why?
|
| Karyotyping | 1 | 2008 | 252 | 0.020 |
Why?
|
| Interleukin-17 | 1 | 2009 | 105 | 0.020 |
Why?
|
| Radiation Chimera | 1 | 2007 | 23 | 0.020 |
Why?
|
| Mastocytosis | 1 | 2007 | 13 | 0.020 |
Why?
|
| Ethyl Methanesulfonate | 1 | 1987 | 4 | 0.020 |
Why?
|
| Metallothionein | 1 | 1987 | 13 | 0.020 |
Why?
|
| Thymidine Kinase | 1 | 1987 | 30 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1990 | 390 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2008 | 286 | 0.020 |
Why?
|
| Cricetulus | 1 | 1987 | 127 | 0.020 |
Why?
|
| Hematologic Neoplasms | 1 | 2011 | 354 | 0.020 |
Why?
|
| Kinetics | 1 | 1990 | 1550 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2008 | 446 | 0.020 |
Why?
|
| Globins | 1 | 1986 | 31 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2008 | 819 | 0.020 |
Why?
|
| Methylation | 1 | 1987 | 276 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 693 | 0.020 |
Why?
|
| Precancerous Conditions | 1 | 2007 | 201 | 0.020 |
Why?
|
| Ovary | 1 | 1987 | 263 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2007 | 281 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2007 | 269 | 0.020 |
Why?
|
| Temperature | 1 | 1987 | 414 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2008 | 419 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 984 | 0.020 |
Why?
|
| Totipotent Stem Cells | 1 | 2005 | 3 | 0.020 |
Why?
|
| 3' Flanking Region | 1 | 2005 | 5 | 0.020 |
Why?
|
| 5' Flanking Region | 1 | 2005 | 16 | 0.020 |
Why?
|
| Gene Order | 1 | 2005 | 23 | 0.020 |
Why?
|
| United States | 1 | 2017 | 7142 | 0.010 |
Why?
|
| Brain | 1 | 2013 | 2328 | 0.010 |
Why?
|
| Prognosis | 1 | 2011 | 3813 | 0.010 |
Why?
|
| Leukopoiesis | 1 | 2002 | 3 | 0.010 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2002 | 78 | 0.010 |
Why?
|
| Milk Proteins | 1 | 2002 | 24 | 0.010 |
Why?
|
| Epidermis | 1 | 2002 | 102 | 0.010 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2001 | 19 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2007 | 1362 | 0.010 |
Why?
|
| NFATC Transcription Factors | 1 | 2001 | 49 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 2000 | 26 | 0.010 |
Why?
|
| Phosphopeptides | 1 | 2000 | 11 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 2364 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2002 | 441 | 0.010 |
Why?
|
| Immediate-Early Proteins | 1 | 2001 | 164 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2000 | 697 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1998 | 29 | 0.010 |
Why?
|
| Human T-lymphotropic virus 1 | 1 | 1998 | 14 | 0.010 |
Why?
|
| Biological Transport | 1 | 1998 | 403 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2002 | 1806 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1997 | 69 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 1997 | 70 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 1997 | 395 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1996 | 511 | 0.010 |
Why?
|
| Models, Biological | 1 | 2002 | 1770 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1997 | 404 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 1993 | 66 | 0.010 |
Why?
|
| Chickens | 1 | 1994 | 212 | 0.010 |
Why?
|
| Keratins | 1 | 1993 | 63 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1993 | 324 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1993 | 354 | 0.010 |
Why?
|
| Time Factors | 1 | 2002 | 5366 | 0.010 |
Why?
|
| Species Specificity | 1 | 1994 | 690 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 1994 | 742 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1994 | 897 | 0.010 |
Why?
|
| Hepatocyte Nuclear Factor 1 | 1 | 1990 | 30 | 0.010 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 1990 | 34 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1990 | 71 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1990 | 173 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1990 | 154 | 0.010 |
Why?
|
| Models, Molecular | 1 | 1994 | 1324 | 0.010 |
Why?
|
| Adult | 1 | 2008 | 26953 | 0.000 |
Why?
|
| Immunologic Techniques | 1 | 1988 | 26 | 0.000 |
Why?
|
| Tissue Distribution | 1 | 1988 | 293 | 0.000 |
Why?
|
| Poly A | 1 | 1986 | 23 | 0.000 |
Why?
|
| Culture Media | 1 | 1986 | 148 | 0.000 |
Why?
|
| Fetal Blood | 1 | 1986 | 93 | 0.000 |
Why?
|
| Embryo, Mammalian | 1 | 1986 | 223 | 0.000 |
Why?
|
| Erythrocytes | 1 | 1986 | 255 | 0.000 |
Why?
|
| Fetus | 1 | 1986 | 232 | 0.000 |
Why?
|
| Liver | 1 | 1988 | 1218 | 0.000 |
Why?
|